InsiderPulse
Dashboard

NTRA

Natera, Inc.

Health CareRussell 2000

Natera, Inc. insider trading

Natera, Inc. files with the SEC as a Services-Medical Laboratories company headquartered in Austin, TX. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent NTRA insider transactions

2 insiders traded NTRA on the open market between Sep 14, 2026 and Sep 16, 2026 — 24 sales worth $25.8M, of which every one was pre-scheduled under a 10b5-1 plan.

Bought
—
Sold
$25.8M

24 of 24 on a 10b5-1 plan

Net
−$25.8M
Insiders
2

Open-market purchases (code P) and sales (code S) from Natera, Inc.'s own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 22, 2026. The live dashboard shows new filings the moment they clear.

Every NTRA Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

NTRA insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 12 insiders traded NTRA on the open market: 0 purchases and 809 sales worth $491.7M, 755 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 445 sales ($316.4M), by 12 insiders.

QuarterBoughtSold
Q2 2026—−$76.1M130 sales · 120 on a plan
Q1 2026—−$123.3M116 sales · all on a plan
Q4 2025—−$91.5M111 sales · 93 on a plan
Q3 2025—−$25.5M88 sales · 87 on a plan
Q2 2025—−$26.2M112 sales · 106 on a plan
Q1 2025—−$72.8M114 sales · 109 on a plan
Q4 2024—−$61.8M94 sales · 81 on a plan
Q3 2024—−$14.4M44 sales · 43 on a plan
Largest sale
−$31.3M of NTRA by Chapman Steven Leonard (CEO And President · Director) on Nov 03, 2025, under a 10b5-1 plan.

Open-market transactions through Jun 30, 2026most recent first

  • Rosenman Herm10b5-1

    Director

    −$4.1M

    Jun 24, 2026

    16,530 sh · $250.00

  • Rabinowitz Daniel10b5-1

    Sec. And Chief Legal Officer

    −$4.1M

    Jun 24, 2026

    16,204 sh · $250.25

  • Rabinowitz Daniel10b5-1

    Sec. And Chief Legal Officer

    −$2.8M

    Jun 24, 2026

    11,130 sh · $253.39

  • Rabinowitz Daniel10b5-1

    Sec. And Chief Legal Officer

    −$1.3M

    Jun 24, 2026

    5,066 sh · $252.31

  • Rabinowitz Daniel10b5-1

    Sec. And Chief Legal Officer

    −$301.9K

    Jun 24, 2026

    1,200 sh · $251.60

  • Sheena Jonathan10b5-1

    Director

    −$66.6K

    Jun 17, 2026

    301 sh · $221.39

  • Sheena Jonathan10b5-1

    Director

    −$58.3K

    Jun 17, 2026

    267 sh · $218.18

  • Sheena Jonathan10b5-1

    Director

    −$55.8K

    Jun 17, 2026

    256 sh · $218.14

  • Sheena Jonathan10b5-1

    Director

    −$54K

    Jun 17, 2026

    244 sh · $221.46

  • Sheena Jonathan10b5-1

    Director

    −$28.1K

    Jun 17, 2026

    128 sh · $219.26

  • Sheena Jonathan10b5-1

    Director

    −$27K

    Jun 17, 2026

    122 sh · $220.93

  • Sheena Jonathan10b5-1

    Director

    −$21K

    Jun 17, 2026

    96 sh · $219.13

  • Sheena Jonathan10b5-1

    Director

    −$15.7K

    Jun 17, 2026

    71 sh · $220.46

  • Sheena Jonathan10b5-1

    Director

    −$3.3K

    Jun 17, 2026

    15 sh · $222.14

  • Chapman Rowan E10b5-1

    Director

    −$642.5K

    Jun 16, 2026

    2,964 sh · $216.78

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Natera, Inc. company record

SEC industry classification
Services-Medical Laboratories
Headquarters
Austin, TX
Incorporated in
DE
Listed on
Nasdaq
SEC Central Index Key
0001604821

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought NTRA

What the stock actually did in the 90 days following each open-market purchase

Don't check NTRA — let it ping you

Get told the moment an insider moves on NTRA

Pro watches Natera, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add NTRA to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track NTRA on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read NTRA insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

CRSPNTLABEAMRXRXTWSTPACBARWRIONSAXSMKRYSRAREFOLD
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are NTRA insiders buying or selling?
Between Sep 14, 2026 and Sep 16, 2026, 2 Natera, Inc. insiders made no open-market purchases and 24 sales worth $25.8M, a net sale of $25.8M. 24 of the sales were pre-scheduled under a Rule 10b5-1 plan.
How much NTRA stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 12 Natera, Inc. insiders made no open-market purchases and 809 sales worth $491.7M. 755 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 445 sales ($316.4M). The largest sale was Chapman Steven Leonard selling $31.3M on Nov 03, 2025.
What was the largest recent NTRA insider trade?
Rabinowitz Matthew (Executive Chairman · Director) sold $5.1M of NTRA stock on Sep 15, 2026 at about $350.81 a share, under a pre-scheduled 10b5-1 plan.
When did an insider last buy NTRA shares?
No open-market purchase by a Natera, Inc. insider appears in the filings from Sep 14, 2026 to Sep 16, 2026 — every recorded open-market transaction in that period was a sale.
Where does NTRA insider trading data come from?
From the Form 4 filings Natera, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.